Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines
Claudia Maria Trombetta, Otfried Kistner, Emanuele Montomoli, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 714-714
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond
Michael D. Parkins, Bonita E. Lee, Nicole Acosta, et al.
Clinical Microbiology Reviews (2023) Vol. 37, Iss. 1
Closed Access | Times Cited: 54
Antiviral PROTACs: Opportunity borne with challenge
Jinsen Liang, Yihe Wu, Ke Lan, et al.
Cell Insight (2023) Vol. 2, Iss. 3, pp. 100092-100092
Open Access | Times Cited: 34
Cardiac tamponade
Yehuda Adler, Arsen Ristić, Massimo Imazio, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 26
High-throughput 96-well plate-based porcine antibody isolation protocol
John M. Byrne, Christina R. Bourne, Sitka Eguiluz, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0320501-e0320501
Open Access | Times Cited: 1
Knowledge, attitude, practice, and barriers among physicians in the Middle East and North Africa region toward influenza vaccination for the high-risk group of patients: a cross-sectional study
Saadi M. Saleh, Alaa Aljamala, Dina Hafez, et al.
Tropical Diseases Travel Medicine and Vaccines (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Concepts and methods for predicting viral evolution
Matthijs Meijers, Denis Ruchnewitz, Jan Eberhardt, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Increased efficacy of influenza virus vaccine candidate through display of recombinant neuraminidase on virus like particles
Leticia Guzman Ruiz, Alexander M Zollner, Irene Hoxie, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity
Joshua Tobias, Peter Steinberger, Joy Wilkinson, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 795-795
Open Access | Times Cited: 5
XBB.1.5‐Adapted COVID‐19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS‐CoV‐2 JN.1 Variant in Patients With Inflammatory Bowel Disease
Simon Woelfel, Joel Dütschler, Daniel Junker, et al.
Alimentary Pharmacology & Therapeutics (2024)
Open Access | Times Cited: 5
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review
Katharine Valéria Saraiva Hodel, Bianca Sampaio Dotto Fiuza, Rodrigo Souza Conceição, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 807-807
Open Access | Times Cited: 4
Concepts and Methods for Predicting Viral Evolution
Matthijs Meijers, Denis Ruchnewitz, Jan Eberhardt, et al.
Methods in molecular biology (2025), pp. 253-290
Closed Access
Novedades de las inmunizaciones en la edad pediátrica
Ana Isabel Dacosta Urbieta, Ángela Manzanares Casteleiro, Irene Rivero‐Calle, et al.
(2025), pp. 6-15
Closed Access
Improved Synthesis for the 4-Pyridone Intermediate of Baloxavir Marboxil: Elimination of Polar Aprotic Solvents and Optimization Through Design of Experiments (DoE)
Jianwu Lu, Yinfei Shi, Kongcheng Huang, et al.
Organic Process Research & Development (2025)
Closed Access
Reduced risks of influenza-associated hospitalization and complications following vaccination among over 2 million older individuals: a nationwide study using target trial emulation framework
Zi‐Yang Peng, Yanqiao Hua, Wan‐Ting Huang, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Targeting Respiratory Viruses: The Efficacy of Intranasal mRNA Vaccination in Generating Protective Mucosal and Systemic Immunity Against Influenza A (H1N1)
Sara Yahyaei, Asghar Abdoli, Abbas Jamali, et al.
Influenza and Other Respiratory Viruses (2025) Vol. 19, Iss. 3
Open Access
Evaluating the Role of Self-Collected Home Swab Data in Enhancing Influenza Vaccine Effectiveness Estimates in General Practice
Monique Chilver, Zahra Ahsani, Sheena G. Sullivan, et al.
(2025)
Closed Access
Evaluation of the influenza vaccine protection in the house dust mite-induced chronic allergic asthma mice model and the evaluation of squalene oil in water emulsion as an adjuvant candidate
So Yeon Ahn, Thi Len Ho, Eun‐Ju Ko
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Epigallocatechin-3-gallate inhibits replication of influenza A virus via restoring the host methylated genes following infection
Dina El Bery, Samir El‐Masry, Adel A. Guirgis, et al.
International Microbiology (2025)
Closed Access
Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern
Ankita Saha, Sounak Ghosh Roy, Richa Dwivedi, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 424-424
Open Access
Corneal complications of common vaccinations
Kartik Gannamaneni, Shahzad I. Mian
Current Opinion in Ophthalmology (2025)
Closed Access
Practice, beliefs and intent in influenza vaccination among Hispanic patients during the pandemic: An interventional study
Jin Mou, Gretchen LaSalle, Chaya Mangel Pflugeisen, et al.
Vaccine (2025) Vol. 58, pp. 127207-127207
Closed Access
Fast and flu-rious: How to prevent and treat emerging influenza A viruses
Isabel Sesifredo, Íris L. Batalha, Maria João Amorim
PLoS Pathogens (2025) Vol. 21, Iss. 5, pp. e1013135-e1013135
Open Access
Molecular surveillance of influenza A virus in Saudi Arabia: whole-genome sequencing and metagenomic approaches
Iman Dandachi, Abdulrahman Alrezaihi, Dashty Mohammed Amin, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 8
Open Access | Times Cited: 3
The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence
Serena Marchi, Elettra Fallani, Marco Salvatore, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 7
Attitudes, motivators, and barriers toward influenza vaccination for children: a study from a conflict-ridden country
Wesam S. Ahmed, Abdulsalam Halboup, Arwa Alshargabi, et al.
Conflict and Health (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top